MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to adaptive...
-$20,033K
(32.89%↑ Y/Y)
Service
$58,093K
(48.12%↑ Y/Y)
Regulatory Milestone
Revenue
$9,000K
(100.00%↑ Y/Y)
Revenue From Contract
With Customer...
$3,781K
Net loss
-$20,015K
(32.90%↑ Y/Y)
Add net income
attributable to...
$18K
(-18.18%↓ Y/Y)
Interest and other
income, net
$2,080K
(-22.36%↓ Y/Y)
MRDRevenue
$67,093K
(53.46%↑ Y/Y)
Immune Medicine
Revenue
$3,781K
(-56.65%↓ Y/Y)
Loss from operations
-$19,206K
(35.12%↑ Y/Y)
Interest expense
$2,889K
(-0.55%↓ Y/Y)
Revenue
$70,874K
(35.14%↑ Y/Y)
Total operating
expenses
$90,080K
(9.79%↑ Y/Y)
Sales and marketing
$26,346K
(14.31%↑ Y/Y)
Research and development
$23,623K
(-2.40%↓ Y/Y)
General and
administrative
$20,984K
(20.60%↑ Y/Y)
Cost of revenue
$18,708K
(10.18%↑ Y/Y)
Amortization of intangible
assets
$419K
(0.00%↑ Y/Y)
Back
Back
Income Statement
Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corp (ADPT)
source: myfinsight.com